Recent progress in the battle between oncolytic viruses and tumours
In the past 5 years, the field of oncolytic virus research has matured significantly and is
moving past the stage of being a laboratory novelty into a new era of preclinical and clinical
trials. What have recent anticancer trials of oncolytic viruses taught us about this exciting
new line of therapeutics?
moving past the stage of being a laboratory novelty into a new era of preclinical and clinical
trials. What have recent anticancer trials of oncolytic viruses taught us about this exciting
new line of therapeutics?
Abstract
In the past 5 years, the field of oncolytic virus research has matured significantly and is moving past the stage of being a laboratory novelty into a new era of preclinical and clinical trials. What have recent anticancer trials of oncolytic viruses taught us about this exciting new line of therapeutics?
nature.com